MedTrace Logo

Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System

NCT07335341 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-05-12

No results posted yet for this study

Summary

The purpose of Case-Specific Health Care Professional (HCP) Clinical Survey of Liberant™ Thrombectomy System, also known as the Liberant Clinical Assessment, is to collect first-in-human clinical data to confirm the safety and performance of the Medtronic Liberant™ thrombectomy system when used for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems

Conditions

  • Venous Embolism of Lower Extremities (Diagnosis)
  • Arterial Embolism and Thrombosis
  • Acute DVT of Lower Extremity
  • Chronic DVT of Lower Extremity
  • DVT
  • Deep Vein Thrombosis Leg
  • Thrombus in the Peripheral Venous Vasculature
  • Peripheral Arterial Disease
  • Acute Limb Ischemia
  • Lower Extremity Acute Limb Ischemia
  • LE ALI

Interventions

DEVICE

Liberant Thrombectomy System

The Liberant thrombectomy system is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems

Sponsors & Collaborators

  • Medtronic Endovascular

    lead INDUSTRY

Principal Investigators

  • John R Laird Jr, MD · Medtronic Endovascular

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-24
Primary Completion
2026-10-31
Completion
2026-10-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07335341 on ClinicalTrials.gov